Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,670
-330 (-2.36%)
May 20, 2026, 3:30 PM KST
Market Cap148.20B -15.6%
Revenue (ttm)195.27B +43.8%
Net Income2.03B
EPS187.00
Shares Out10.84M
PE Ratio73.10
Forward PE10.30
Dividend300.00 (2.14%)
Ex-Dividend DateDec 29, 2025
Volume39,455
Average Volume45,966
Open14,000
Previous Close14,000
Day's Range13,550 - 14,000
52-Week Range13,550 - 20,900
Beta0.66
RSI23.04
Earnings DateMay 22, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

Financial Statements